The influenceof implantationcava filter on the hospitaltreatment resultsof patients withpulmonary embolismand a high-intermediate risk

Abstract


The article devoted to the study of pulmonary embolism and a high-intermediate risk in
117 patients ranging in age from 48,5 to 65,3 treated at the Samara regional clinical cardiology
dispensary. An assessment of the influence of implantation cava filter in the inferior vena
cava in addition to standard therapy with heparin or thrombolytic on the hospital treatment
result. It is shown that the implantation of cava filter does not influence on the degree of
pressure reduction in pulmonary artery applied by standard methods of treatment and does
not contribute to the development of a higher incidence of residual pulmonary hypertension
at the time of discharge from hospital, while reducing hospital mortality rate regardless of the
main and common method of treatment (thrombolytic therapy or standard heparin one).

About the authors

E A Kurakina

E A Kurakina

References

  1. Ingber S, Geerts WH.Vena caval filters: current knowledge, uncertainties and practical approaches. Curr Opin Hematol. 2009 Sep;16(5):402-6.
  2. Флебология: Руководство для врачей/Савельев В.С., Гологорский В.А., Кириенко А.И. и др: Под ред. В.С. Савельева. М.: Медицина, 2001-664 с.
  3. Pollack СV, Schreiber D, Goldhaber SZ. Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department. Initial Report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol, 2011; 57:700-706
  4. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259-262.
  5. Hoppe H. Optional Vena Cava Filters. Indications, management and results. Dtsch Arztebl Int. 2009, June; 106(24): 395-402
  6. Савельев В.С., Яблоков Е.Г., Кириенко А.И. Массивная эмболия легочных артерий. М.: Медицина, 1990г, 336с.; Becker D.M., Philbrick J.T., Selby J.B. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med. 1992 Oct;152(10):1985-94.
  7. Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino), 2008 Feb;49(1):35-49.
  8. Young T, Aukes J, Hughes R, Tang H. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006212.
  9. Young T, Tang H, Hughes R. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006212.
  10. Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29, 2276-2315
  11. Wicki J, Perneger TV, Junod AF et al. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001;161: 92-7.
  12. Тромбоэмболия легочной артерии, учебное пособие. Павлова Т.В, Поляков В.П., Савельева Г.Г и др.Самара, 2009, 49 с.
  13. Perez de Llano LA, Baloira VA, Veres RA et al. [Multicenter, prospective study comparing enoxaparin with unfractionated heparin in the treatment of submassive pulmonary thromboembolism]. Arch Bronconeumol. 2003;39:341-345.
  14. Флебология: Руководство для врачей/Савельев В.С., Гологорский В.А., Кириенко А.И. и др: Под ред. В.С. Савельева. М.: Медицина, 2001-664 с.
  15. Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29, 2276-2315
  16. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология, том 4, выпуск2, 1,2010
  17. Hoppe H. Optional Vena Cava Filters. Indications, management and results. Dtsch Arztebl Int. 2009, June; 106(24): 395-402
  18. Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29, 2276-2315
  19. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология, том 4, выпуск2, 1,2010
  20. Moser K.M., Auger W.R., Fedullo P.F. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990;81:1735-43.; Pengo V., Lensing A.W., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl JMed 2004;350:2257-64.
  21. Rich S, ed. Executive summary from the World Symposium on Primary Pulmonary Hypertension 1998, Evian, France, September 6-10, 1998, cosponsored by the World Health Organization. Retrieved April 14, 2000, from the World Wide Web: http://www.who.int/ncd/cvd/pph.html.
  22. Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes GM et al. Streptokinase and heparin versus heparin alone in massive pulmo nary embolism: a randomized controlled trial. J Thromb Thrombolysis. 1995; 2:227-229.
  23. Konstantinides S, Geibel A, Heusel G et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347:1143-1150.
  24. Decousus H., Leizorovicz A., Parent F. Et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d`Embolie pulmonaire par interruption cave study. N. Engl. J. Med..-1998.-338.- Р. 409-415.

Statistics

Views

Abstract - 26

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2012 Kurakina E.A., Kurakina E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies